|
|
Osteoarthritis drug safety fears
Another Osteoarthritis painkiller withdrawn from the UK market. Fears over the safety of arthritis painkiller Lumiracoxib (‘Prexige’) have resulted in it being suspended by the Medicines and Healthcare products Regulatory Agency (MHRA).
Lumiracoxib has been suspended after concerns it may be causing liver damage. This follows the prescribing restrictions and additional requirements for blood tests before and during Lumiracoxib treatment for all other patients, which was issued in August 2007.
Osteoarthritis is a common and sometimes disabling condition and with fewer and fewer pain relieving options maybe its time for sufferers to consider alternative approaches to pain relief.
Cyril Pragnell a very experienced osteopath practising in Middlesex explains how osteopathy is able to reduce the symptoms and improve the functioning of osteoarthritic joints. “Joints are made to move, osteopathic treatment takes the joint through its normal range of movement, encouraging the circulation and nutrition to the joint which works as a natural pain reliever”.
Having just come from a lecture on medications, he also reports that “a lot of the drugs currently available on the market are a huge health risk for patients over the age of 70, many cause stomach erosion”.
If you are suffering from arthritis and are concerned about the risks of drugs you have been prescribed the drug-free approach advocated by Osteopaths may be your answer. Osteopaths have great success with treating arthritis and will be happy to advise you on your specific condition and how it could be treated without drugs. News Archive
Tags : alternative,
arthritis,
blood,
osteoarthritis
RSS Feed : 
|